{"id":13103,"date":"2021-05-11T17:10:44","date_gmt":"2021-05-11T15:10:44","guid":{"rendered":"https:\/\/profertil.eu\/?page_id=13103"},"modified":"2023-10-09T11:19:46","modified_gmt":"2023-10-09T09:19:46","slug":"estudio-de-adn-2019","status":"publish","type":"page","link":"https:\/\/profertil.eu\/es\/estudios\/estudio-de-adn-2019\/","title":{"rendered":"Estudio de ADN 2019"},"content":{"rendered":"\n
\"\"
\n

REDUCE
DNA FRAGMENTATION<\/span><\/h1>\n<\/div><\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n

\u00bbReducci\u00f3n importante de la fragmentaci\u00f3n del ADN en el esperma\u00ab<\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n
<\/div>\n\n\n\n

ESTUDIO DE ADN 2019<\/p>\n\n\n\n

Reducci\u00f3n de la fragmentaci\u00f3n del ADN del esperma (en un %) tras tres meses tomando PROFERTIL\u00ae<\/sup><\/strong><\/h3>\n<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\"Aspire,<\/figure>\n\n\n\n
<\/div>\n\n\n\n

N\u00famero de pacientes<\/strong>:<\/strong>
n = 306
(Grupo PROFERTIL\u00ae: n = 146;
grupo de control: n = 160)

Presentaci\u00f3n<\/strong>:<\/strong>
Aspire 2019, Hongkong;
en proceso de publicaci\u00f3n<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
La composici\u00f3n \u00fanica y patentada de <\/strong> PROFERTIL\u00ae<\/h6>\n\n\n\n